ME
McIlrath & Eck’s Vanguard Health Care ETF VHT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $34.5K | Sell |
139
-104
| -43% | -$25.8K | ﹤0.01% | 386 |
|
2025
Q1 | $64.3K | Buy |
243
+100
| +70% | +$26.5K | 0.01% | 266 |
|
2024
Q4 | $36.3K | Sell |
143
-111
| -44% | -$28.2K | ﹤0.01% | 380 |
|
2024
Q3 | $71.7K | Hold |
254
| – | – | 0.01% | 238 |
|
2024
Q2 | $67.6K | Sell |
254
-8
| -3% | -$2.13K | 0.01% | 234 |
|
2024
Q1 | $70.9K | Sell |
262
-20
| -7% | -$5.41K | 0.01% | 230 |
|
2023
Q4 | $70.7K | Buy |
282
+164
| +139% | +$41.1K | 0.01% | 216 |
|
2023
Q3 | $27.7K | Hold |
118
| – | – | 0.01% | 351 |
|
2023
Q2 | $28.9K | Hold |
118
| – | – | 0.01% | 351 |
|
2023
Q1 | $28.1K | Buy |
118
+101
| +594% | +$24.1K | 0.01% | 347 |
|
2022
Q4 | $4.22K | Sell |
17
-95
| -85% | -$23.6K | ﹤0.01% | 664 |
|
2022
Q3 | $25K | Buy |
112
+10
| +10% | +$2.23K | 0.01% | 365 |
|
2022
Q2 | $24K | Buy |
102
+2
| +2% | +$471 | 0.01% | 357 |
|
2022
Q1 | $25K | Hold |
100
| – | – | 0.01% | 357 |
|
2021
Q4 | $27K | Hold |
100
| – | – | 0.01% | 347 |
|
2021
Q3 | $25K | Hold |
100
| – | – | 0.01% | 358 |
|
2021
Q2 | $25K | Sell |
100
-13
| -12% | -$3.25K | 0.01% | 352 |
|
2021
Q1 | $26K | Buy |
113
+13
| +13% | +$2.99K | 0.01% | 304 |
|
2020
Q4 | $22K | Hold |
100
| – | – | 0.01% | 289 |
|
2020
Q3 | $20K | Hold |
100
| – | – | 0.01% | 269 |
|
2020
Q2 | $19K | Hold |
100
| – | – | 0.01% | 252 |
|
2020
Q1 | $17K | Hold |
100
| – | – | 0.01% | 223 |
|
2019
Q4 | $19K | Buy |
+100
| New | +$19K | 0.01% | 252 |
|
2019
Q3 | – | Sell |
-130
| Closed | -$22K | – | 670 |
|
2019
Q2 | $22K | Hold |
130
| – | – | 0.01% | 186 |
|
2019
Q1 | $22K | Sell |
130
-37
| -22% | -$6.26K | 0.01% | 186 |
|
2018
Q4 | $27K | Buy |
167
+100
| +149% | +$16.2K | 0.02% | 161 |
|
2018
Q3 | $12K | Hold |
67
| – | – | 0.01% | 273 |
|
2018
Q2 | $11K | Hold |
67
| – | – | 0.01% | 270 |
|
2018
Q1 | $10K | Hold |
67
| – | – | 0.01% | 266 |
|
2017
Q4 | $10K | Buy |
+67
| New | +$10K | 0.01% | 284 |
|